compulsory license
KEI requests an open compulsory license relating to Paxlovid in the Dominican Republic
On Friday, December 3, 2021, KEI requested an open public interest license to allow the exploitation of PF-07321332 (marketed in combination with ritonavir under the brand Paxlovid) in the Dominican Republic. PF-07321332, being developed by Pfizer, has shown promising results… Continue Reading
Bolivia seeks to import COVID-19 vaccines from Biolyse, if Canada grants them a compulsory license
Today the government of Bolivia and Biolyse, a company based in Canada, signed an agreement to acquire COVID-19 vaccines manufactured by the company, if Canada grants them a compulsory license. Biolyse is a manufacturer of cancer drugs with the potential… Continue Reading
KEI Briefing Note 2021:2 Canadian Experience with Compulsory Licensing under the Canadian Access to Medicines Regime
Verinata v. Ariosa – compulsory license granted to Roche over prenatal screening technologies under eBay v. MercExchange
On July 19, 2018, the U.S. District Court, Northern District of California, denied a permanent injunction requested by Illumina, Inc, and instead ruled that a forward looking royalty for continued non-voluntary use of the invention, a type of compulsory license,… Continue Reading
2019: KEI Comments Submitted to USTR Special 301 Review
On Thursday February 7, 2019, KEI submitted comments and intent to testify at the hearing for the 2019 US Trade Representative’s Special 301 review process. This year’s hearing will take place on Wednesday February 27, 2019 at the Office of… Continue Reading
Chilean Cámara de Diputados Overwhelmingly Asks the Ministry of Health to Proceed with Compulsory Licenses for HCV drugs
On June 8, 2018 the Cámara de Diputados of the Chilean Congress overwhelmingly passed a resolution calling on the Ministry of Health to proceed with compulsory licenses on patents covering hepatitis C virus (HCV) drugs. Resolution No. 68, passed with… Continue Reading
KEI joins unions, NGOs, Payors in Calling on Judiciary Committee to Vote in Favor of CREATES Act
KEI has joined unions, NGOs and payors on a letter sent to Senator Grassley and Sen. Feinstein, the chair and ranking member of the Judiciary Committee, thanking them for their support of the Creating and Restoring Equal Access to Equivalent… Continue Reading
13 NGOs Call on USTR To Support Colombia in Special 301 Following Pressure Over Legal Access to Meds Efforts
KEI submitted a post-hearing submission to the USTR for the Special 301 on behalf of itself and twelve other international NGOs and academic institutions condemning recent pressures on Colombia’s legal and regulatory measures to increase access to affordable medicines, including… Continue Reading